OKAIF (EvokAI Creative Labs) EPS (Basic) : $-1.84 (TTM As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is EvokAI Creative Labs EPS (Basic)?

EvokAI Creative Labs's basic earnings per share (Basic EPS) for the three months ended in Sep. 2024 was $-0.03. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2024 was $-1.84.

EvokAI Creative Labs's EPS (Diluted) for the three months ended in Sep. 2024 was $-0.03. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $-1.84.

EvokAI Creative Labs's EPS without NRI for the three months ended in Sep. 2024 was $-0.03. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2024 was -0.25.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

EvokAI Creative Labs EPS (Basic) Historical Data

The historical data trend for EvokAI Creative Labs's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EvokAI Creative Labs EPS (Basic) Chart

EvokAI Creative Labs Annual Data

Trend

Dec21

Dec22

Dec23

EPS (Basic)

-0.90

-2.50

EvokAI Creative Labs Quarterly Data
	Dec21	Mar22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EPS (Basic)	Get a 7-Day Free Trial						-0.03	-1.67	-0.10	-0.04	-0.03

EvokAI Creative Labs EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

EvokAI Creative Labs's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-17.083	-	0)	/	6.766
	=	-2.52

EvokAI Creative Labs's Basic EPS for the quarter that ended in Sep. 2024 is calculated as

Basic EPS (Q: Sep. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.205	-	0)	/	7.605
	=	-0.03

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.84

EvokAI Creative Labs (OTCPK:OKAIF) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

EvokAI Creative Labs EPS (Basic) Related Terms

Thank you for viewing the detailed overview of EvokAI Creative Labs's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

EvokAI Creative Labs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » EvokAI Creative Labs Inc (OTCPK:OKAIF) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

OKAI:Canada

Address

609 Granville Street, Suite 1600, PO Box 10068, Pacific Centre, Vancouver, BC, CAN, V7Y 1C3

Website

https://www.evokailabs.com

EvokAI Creative Labs Inc is a medtech artificial-intelligence-powered company. It deploys machine learning models to search medical data and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide more accurate diagnoses. EvokAI tailors its AI algorithms across the whole healthcare system, from hospitals, private clinics, research institutions, pharmaceutical companies, and contract research organizations to medical professionals, patients, and healthy individuals aiming at preventing and early detecting any kind of disease and beyond, protecting the aging genome.